carbenoxolone sodium has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JH; Hong, CH; Lee, KH; Lee, KS; Oh, BH; Shin, MJ | 1 |
| Nehru, B; Saini, A; Saini, R; Sharma, P; Sharma, S | 1 |
| Nehru, B; Saini, A; Sharma, S | 1 |
| Nehru, B; Saini, A; Sharma, N; Sharma, S | 1 |
| Doi, Y; Jin, S; Kawanokuchi, J; Li, E; Li, H; Liang, J; Mizoguchi, H; Mizuno, T; Mori, R; Noda, M; Parajuli, B; Sato, J; Sobue, G; Sonobe, Y; Suzumura, A; Takeuchi, H; Yamanaka, K; Yasuoka, S; Zhou, Y | 1 |
| Suzumura, A | 1 |
6 other study(ies) available for carbenoxolone sodium and Alzheimer Disease
| Article | Year |
|---|---|
Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Chemokine CXCL9; Cognition Disorders; Cytokines; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Polymers; Prognosis | 2008 |
Maintenance of Amyloid-beta Homeostasis by Carbenoxolone Post Aβ-42 Oligomer Injection in Rat Brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carbenoxolone; Homeostasis; Rats; Ubiquitin | 2020 |
Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Binding Sites; Carbenoxolone; Humans; Molecular Docking Simulation; Peptide Fragments; Protein Aggregation, Pathological | 2017 |
Carbenoxolone Reverses the Amyloid Beta 1-42 Oligomer-Induced Oxidative Damage and Anxiety-Related Behavior in Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Anxiety Agents; Antioxidants; Anxiety; Brain; Carbenoxolone; Gap Junctions; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Protein Carbonylation; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |
Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carbenoxolone; Disease Progression; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; Ion Channels; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Spinal Cord; Superoxide Dismutase | 2011 |
[Microglia and neuronal degeneration].
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Carbenoxolone; Cytokines; Disease Models, Animal; Drug Design; Glutamates; Humans; Microglia; Molecular Targeted Therapy; Multiple Sclerosis; Nerve Degeneration; Neurogenic Inflammation | 2010 |